Loading...
XLON
AMS
Market cap809mUSD
Jul 09, Last price  
279.00GBP
1D
0.18%
1Q
32.86%
Jan 2017
25.82%
IPO
3,221.43%
Name

Advanced Medical Solutions Group PLC

Chart & Performance

D1W1MN
XLON:AMS chart
P/E
60.66
P/S
2.64
EPS
0.05
Div Yield, %
0.66%
Shrs. gr., 5y
0.20%
Rev. gr., 5y
21.41%
Revenues
229m
+28.96%
14,322,00016,856,00020,316,00024,091,00031,881,00034,353,00052,589,00059,499,00063,010,00068,596,00083,242,00096,908,000102,598,000102,368,00086,796,000108,601,000124,330,000126,210,000177,521,000228,936,000
Net income
10m
+40.32%
747,0002,236,0003,309,0002,784,0004,833,0004,850,0009,692,00011,366,00012,864,00014,119,00015,692,00020,134,00022,650,00018,919,0008,584,00017,481,00020,406,00015,889,0007,094,0009,954,000
CFO
29m
+47.51%
1,479,0003,671,0002,740,0002,026,0007,010,0004,849,00011,893,00014,070,00016,572,00021,291,00019,825,00016,966,00021,674,00021,412,00021,053,00030,409,00027,080,00012,345,00019,489,00028,749,000
Dividend
May 28, 20262.01 GBP/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Advanced Medical Solutions Group plc (AMS), along with its subsidiaries, specializes in the innovation, production, and worldwide distribution of advanced medical solutions. Its primary markets include wound treatment, surgical procedures, and wound closure, with a significant presence across the United Kingdom, Germany, France, wider Europe, the United States, and other international regions. The company's operations are structured into two main divisions: Surgical and Woundcare. The Surgical segment provides a comprehensive range of specialized products. These include topical tissue adhesives for sealing and closing wounds, offered under the LiquiBand brand; sutures and collagen-derived materials for surgical and dental applications, marketed as RESORBA; various collagen products; the LiquiBand Fix8 laparoscopic device designed for internally securing hernia meshes; and internal sealants available under the Seal-G and Seal-G MIST brands. Conversely, the Woundcare segment focuses on a broad spectrum of sophisticated wound management technologies. Its offerings comprise alginates, medical foams, films, fibers, hydrogels, antimicrobial dressings, and hydrocolloids, alongside a dedicated line of wound care products under the ActivHeal brand. Established in 1991, Advanced Medical Solutions Group plc maintains its corporate headquarters in Winsford, United Kingdom.
IPO date
Apr 30, 2002
Employees
800
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT